Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation-Reference-Cited by-同舟云学术

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

Published:2018-04-03 Issue:7 Volume:2 Page:769-776
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Sidiqi M Hasib¹^ORCID,Aljama Mohammed A.¹,Muchtar Eli¹,Buadi Francis K.¹,Warsame Rahma¹,Lacy Martha Q.¹,Dispenzieri Angela¹,Dingli David¹,Leung Nelson¹,Gonsalves Wilson I.¹,Kumar Shaji K.¹,Kapoor Prashant¹,Kourelis Taxiarchis V.¹,Hogan William J.¹,Gertz Morie A.¹^ORCID

Affiliation:

1. Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, MN

Abstract

Key Points λ Light chain AL amyloidosis is associated with a shorter PFS and OS compared with κ. Light chain type predicts likelihood of organ involvement in AL amyloidosis.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/2/7/769/880617/advances016782.pdf

Reference33 articles.

1. The systemic amyloidoses;Falk;N Engl J Med,1997

2. Amyloidosis: pathogenesis and new therapeutic options;Merlini;J Clin Oncol,2011

3. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens;Vrana;Blood,2009

4. Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis;Kourelis;J Clin Oncol,2013

5. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements;Kumar;J Clin Oncol,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation;Bone Marrow Transplantation;2023-12-26

2. A proteomic atlas of kidney amyloidosis provides insights into disease pathogenesis;Kidney International;2023-12

3. Amiloidosis sistémica con énfasis en amiloidosis de cadenas livianas de inmunoglobulinas;Medicina y Laboratorio;2023-09-21

4. Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease;Hematological Oncology;2023-03-27

5. Diagnosis of Amyloidosis: Clinicopathological Advances and Challenges;Protein Detection - New Research and Technology Advances [Working Title];2023-02-09